Approvals/CIMA-AEMPS/ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION

Approved

STANDARD

ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION

Novartis Europharm Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 576ecf86b920981c
Drug Cima Aemps Name: ZOLGENSMA 2 x 10e13 GENOMAS VECTORIALES/ML SOLUCION PARA PERFUSION
Register Number: 1201443001
Holder Company Name: Novartis Europharm Limited
Marketing Company Name: Novartis Farmaceutica S.A.
Holder Company Detail Path: /organization/novartis-europharm-limited
Authorization Date: 2020-07-28
Dosage Form: SOLUCIÓN PARA PERFUSIÓN
Dose: 2 x 10e13 genomas vectoriales/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Novartis Europharm Limited
Company Detail Path: /organization/novartis-europharm-limited

ONASEMNOGEN ABEPARVOVEC

2 x 10e13 Genoma vectorial

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 28, 2020

Approval ID

576ecf86b920981c

Type

Standard